A database of antimalarial drug resistance

Malaria Journal

Volumn 5, Issue , 2006, Pages

  Sibley, Carol Hopkins ^a   Ringwald, Pascal ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTEMETHER PLUS BENFLUMETOL; ARTEMISININ DERIVATIVE; ARTESUNATE; ARTESUNATE PLUS CHLORPROGUANIL PLUS DAPSONE; ARTESUNATE PLUS PYRONARIDINE; CHLOROQUINE; DIHYDROARTEMISININ PLUS PIPERAQUINE; FANSIDAR; MEFLOQUINE; UNCLASSIFIED DRUG;

CLINICAL EFFECTIVENESS; CLINICAL TRIAL; DATA BASE; DRUG EFFICACY; DRUG MONITORING; DRUG SURVEILLANCE PROGRAM; DRUG USE; HUMAN; IN VITRO STUDY; MALARIA; MEDICAL INFORMATION; MEDICAL RECORD; META ANALYSIS; NONHUMAN; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION;

ANIMALS; ANTIMALARIALS; DATABASES, FACTUAL; DRUG RESISTANCE; HUMANS; INTERNATIONAL COOPERATION; MALARIA, FALCIPARUM; MALARIA, VIVAX; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

EID: 33747056890     PISSN: 14752875     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-5-48     Document Type: Review

References (70)

1. Peters W: Chemotherapy and drug resistance in malaria. second edition. London, Academic Press; 1987.
2. White NJ: Delaying antimalarial drug resistance with combination chemotherapy. Parassitologia 1999, 41:301-308.
3. Trape JF: The public health impact of chloroquine resistance in Africa. Am J Trop Med Hyg 2001, 64:12-17.
4. Snow RW, Trape JF, Marsh K: The past, present and future of childhood malaria mortality in Africa. Trends Parasitol 2001, 17:593-597.
5. Africa Malaria Report2003. Geneva, World Health Organization, WHO/AFRO , UNICEF; 2003.
6. Gardner MJ, Hall N, Fung E, White O, Berriman M, Hyman RW, Carlton JM, Pain A, Nelson KE, Bowman S, Paulsen IT, James K, Eisen JA, Rutherford K, Salzberg SL, Craig A, Kyes S, Chan MS, Nene V, Shallom SJ, Suh B, Peterson J, Angiuoli S, Pertea M, Allen J, Selengut J, Haft D, Mather MW, Vaidya AB, Martin DM, Fairlamb AH, Fraunholz MJ, Roos DS, Ralph SA, McFadden GI, Cummings LM, Subramanian GM, Mungall C, Venter JC, Carucci DJ, Hoffman SL, Newbold C, Davis RW, Fraser CM, Barrell B: Genome sequence of the human malaria parasite Plasmodium falciparum. Nature 2002, 419:498-511.
7. Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, Magill AJ, Su XZ: Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 2002, 418:320-323.
8. Nair S, Williams JT, Brockman A, Paiphun L, Mayxay M, Newton PN, Guthmann JP, Smithuis FM, Hien TT, White NJ, Nosten F, Anderson TJ: A selective sweep driven by pyrimethamine treatment in Southeast Asian malaria parasites. Mol Biol Evol 2003, 20:1526-1536.
9. Roper C, Pearce R, Bredenkamp B, Gumede J, Drakeley C, Mosha F, Chandramohan D, Sharp B: Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet 2003, 361:1174-1181.
10. Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T: Intercontinental Spread of Pyrimethamine-Resistant Malaria. Science 2004, 305:1124.
11. Cortese JF, Caraballo A, Contreras CE, Plowe CV: Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. J Infect Dis 2002, 186:999-1006.
12. Hastings IM: The origins of antimalarial drug resistance. Trends Parasitol 2004, 20:512-518.
13. Susceptibility of Plasmodium falciparum to antimalarial drugs : report on global monitoring : 1996-2004. Geneva, World Health Organization; 2005:146.
14. Arrow KJ, Panosian CB, Gelband H: Saving lives, buying time: Economics of malaria drugs in an age of resistance. Washington, DC, The National Academies Press; 2004:364.
15. Hutagalung R, Paiphun L, Ashley EA, McGready R, Brockman A, Thwai KL, Singhasivanon P, Jelinek T, White NJ, Nosten FH: A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand. Malar J 2005, 4:46.
16. Bloland PB, Ettling M, Meek S: Combination therapy for malaria in Africa: hype or hope? Bull World Health Organ 2000, 78:1378-1388.
17. Shretta R, Omumbo J, Rapuoda B, Snow RW: Using evidence to change antimalarial drug policy in Kenya. Trop Med Int Health 2000, 5:755-764.
18. Rojanawatsirivet C, Congpuong K, Vijaykadga S, Thongphua S, Thongsri K, Bangchang KN, Wilairatana P, Wernsdorfer WH: Declining mefloquine sensitivity of Plasmodium falciparum along the Thai-Myanmar border. Southeast Asian J Trop Med Public Health 2004, 35:560-565.
19. Brockman A, Price RN, van Vugt M, Heppner DG, Walsh D, Sookto P, Wimonwattrawatee T, Looareesuwan S, White NJ, Nosten F: Plasmodium falciparum antimalarial drug susceptibility on the north-western border of Thailand during five years of extensive use of artesunate-mefloquine. Trans R Soc Trop Med Hyg 2000, 94:537-544.
20. Huong NM, Hewitt S, Davis TM, Dao LD, Toan TQ, Kim TB, Hanh NT, Phuong VN, Nhan DH, Cong LD: Resistance of Plasmodium falciparum to antimalarial drugs in a highly endemic area of southern Viet Nam: a study in vivo and in vitro. Trans R Soc Trop Med Hyg 2001, 95:325-329.
21. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RA, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV: Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. J Infect Dis 2002, 185:380-388.
22. Djimde A, Doumbo OK, Cortese JF, Kayentao K, Doumbo S, Diourte Y, Dicko A, Su XZ, Nomura T, Fidock DA, Wellems TE, Plowe CV, Coulibaly D: A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 2001, 344:257-263.
23. Djimde A, Doumbo OK, Steketee RW, Plowe CV: Application of a molecular marker for surveillance of chloroquine- resistant falciparum malaria. Lancet 2001, 358:890-891.
24. Interdisciplinary Monitoring Project for Antimalarial Combination Therapy in Tanzania. .
25. EANMAT: Monitoring antimalarial drug resistance within National Malaria Control Programmes: the EANMAT experience. Trop Med Int Health 2001, 6:891-898.
26. EANMAT: The efficacy of antimalarial monotherapies sulphadoxine- pyrimethamine and amodiaquine in East Africa: implications for sub-regional policy. Trop Med Int Health 2003, 8:860-867.
27. East African network for Monitoring Antimalarial Treatment [http://www.eanmat.org/]
28. Pasteur Network [http://www.pasteur-international.org/english/maladies/ paludisme.html]
29. Global Emerging Infections System [http://www.afrims.org/geis.html]
30. Multilateral Initiatve Against Malaria [http://www.nlm.nih.gov/adrn/ description.html]
31. Walliker D, Hunt P, Babiker H: Fitness of drug-resistant malaria parasites. Acta Trop 2005, 94:251-259.
32. Carlton JM, Angiuoli SV, Suh BB, Kooij TW, Pertea M, Silva JC, Ermolaeva MD, Allen JE, Selengut JD, Koo HL, Peterson JD, Pop M, Kosack DS, Shumway MF, Bidwell SL, Shallom SJ, Van Aken SE, Riedmuller SB, Feldblyum TV, Cho JK, Quackenbush J, Sedegah M, Shoaibi A, Cummings LM, Florens L, Yates JR, Raine JD, Sinden RE, Harris MA, Cunningham DA, Preiser PR, Bergman LW, Vaidya AB, Van Lin LH, Janse CJ, Waters AP, Smith HO, White OR, Salzberg SL, Venter JC, Fraser CM, Hoffman SL, Gardner MJ, Carucci DJ: Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii. Nature 2002, 419:512-519.
33. Carlton JM, Fidock DA, Djimde A, Plowe CV, Wellems TE: Conservation of a novel vacuolar transporter in Plasmodium species and its central role in chloroquine resistance of P. falciparum. Curr Opin Microbiol 2001, 4:415-420.
34. Peters W, Stewart LB, Robinson BL: The chemotherapy of rodent malaria. LXIII. Drug combinations to impede the selection of drug resistance, part 6: the potential value of chlorproguanil and dapsone in combination, and with the addition of artesunate. Ann Trop Med Parasitol 2005, 99:457-472.
35. Plowe CV: Monitoring antimalarial drug resistance: making the most of the tools at hand. J Exp Biol 2003, 206:3745-3752.
36. Staedke SG, Sendagire H, Lamola S, Kamya MR, Dorsey G, Rosenthal PJ: Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda. Trop Med Int Health 2004, 9:624-629.
37. Kyabayinze D, Cattamanchi A, Kamya MR, Rosenthal PJ, Dorsey G: Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria. Am J Trop Med Hyg 2003, 69:247-252.
38. Kublin JG, Cortese JF, Njunju EM, RA M, Wirima JJ, Kazembe PN, Djimde AA, Kouriba B, Taylor TE, Plowe CV: Reemergence of Chloroquine-Sensitive Plasmodium falciparum Malaria after Cessation of Chloroquine Use in Malawi. J Infect Dis 2003, 187:1870-1875.
39. Nelson AL, Purfiled A, McDaniel P, Uthaimongkol N, Buathong N, Sriwichai S, Miller RS, Wongsrichanalai C, Meshnick SR: pfmdr1 genotyping and in vivo mefloquine resistance on the Thaimyanmar border. Am J Trop Med Hyg 2005, 72:586-592.
40. Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, Nosten F, Krishna S: Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 2004, 364:438-447.
41. Ferdig MT, Cooper RA, Mu J, Deng B, Joy DA, Su XZ, Wellems TE: Dissecting the loci of low-level quinine resistance in malaria parasites. Mol Microbiol 2004, 52:985-997.
42. Eckstein-Ludwig U, Webb RJ, Van Goethem ID, East JM, Lee AG, Kimura M, O'Neill PM, Bray PG, Ward SA, Krishna S: Artemisinins target the SERCA of Plasmodium falciparum. Nature 2003, 424:957-961.
43. Plowe CV: Antimalarial drug resistance in Africa: strategies for monitoring and deterrence. Curr Top Microbiol Immunol 2005, 295:55-79.
44. Baird JK: Chloroquine Resistance in Plasmodium vivax. Antimicrob Agents Chemother 2004, 48:4075-4083.
45. Baird JK: Effectiveness of Antimalarial Drugs. N Engl J Med 2005, 352:1565-1577.
46. HIV Drug Resistance Database [http://resdb.lanl.gov/Resist_DB/default. htm]
47. Le Sueur D, Binka F, Lengeler C, De Savigny D, Snow B, Teuscher T, Toure Y: An atlas of malaria in Africa. Afr Health 1997, 19:23-24.
48. Snow RW, Craig MH, Deichmann U, le Sueur D: A preliminary continental risk map for malaria mortality among African children. Parasitol Today 1999, 15:99-104.
49. Mapping Malaria Risk in Africa [http://www.mara.org.za/about.htm]
50. Global Atlas of Infectious Diseases: Malaria Drug Resistance [http://globalatlas.who.int/GlobalAtlas/InteractiveMap/rmm/default.asp?cat1= 020000000000&cat2=020100000000&cat3=020101000000&lev=3]
51. Ruebush TKII, Marquiño W, Zegarra J, Neyra D, Villaroel R, Avila JC, Díaz C, Beltrán E: Practical aspects of in vivo antimalarial drug efficacy testing in the Americas. American Journal of Tropical Medicine and Hygiene 2003, 68:391-397.
52. Monitoring antimalarial drug resistance:a report of a consultation. , World Health Organization; 2003.
53. Slater M, Kiggundu M, Dokomajilar C, Kamya MR, Bakyaita N, Talisuna A, Rosenthal PJ, Dorsey G: Distinguishing recrudescences from new infections in antimalarial clinical trials: major impact of interpretation of genotyping results on estimates of drug efficacy. Am J Trop Med Hyg 2005, 73:256-262.
54. Cochrane Reviews [http://www.cochrane.org/index2.htm]
55. Omari AA, Gamble C, Garner P: Artemether-lumefantrine (four-dose regimen) for treating uncomplicated falciparum malaria. Cochrane Database Syst Rev 2006:CD005965.
56. Hwang J, Bitarakwate E, Pai M, Reingold A, Rosenthal PJ, Dorsey G: Chloroquine or amodiaquine combined with sulfadoxinepyrimethamine for uncomplicated malaria: a systematic review. Tropical Medicine and International Health 2006, 11:789-799.
57. Meremikwu MM, Omari AA, Garner P: Chemoprophylaxis and intermittent treatment for preventing malaria in children. Cochrane Database Syst Rev 2005:CD003756.
58. Orton L, Garner P: Drugs for treating uncomplicated malaria in pregnant women. Cochrane Database Syst Rev 2005:CD004912.
59. Sim I, Detmer DE: Beyond Trial Registration: A Global Trial Bank for Clinical Trial Reporting. PLoS Medicine 2005, 2:.
60. Stepniewska K, Taylor WR, Mayxay M, Price R, Smithuis F, Guthmann JP, Barnes K, Myint HY, Adjuik M, Olliaro P, Pukrittayakamee S, Looareesuwan S, Hien TT, Farrar J, Nosten F, Day NP, White NJ: In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up. Antimicrob Agents Chemother 2004, 48:4271-4280.
61. Myint HY, Tipmanee P, Nosten F, Day NP, Pukrittayakamee S, Looareesuwan S, White NJ: A systematic overview of published antimalarial drug trials. Trans R Soc Trop Med Hyg 2004, 98:73-81.
62. Noedl H, Wongsrichanalai C, Wernsdorfer WH: Malaria drug-sensitivity testing: new assays, new perspectives. Trends Parasitol 2003, 19:175-181.
63. Noedl H: Artemisinin resistance: how can we find it? Trends in Parasitology 2005, 21:404-405.
64. Pearce RJ, Drakeley C, Chandramohan D, Mosha F, Roper C: Molecular Determination of Point Mutation Haplotypes in the Dihydrofolate Reductase and Dihydropteroate Synthase of Plasmodium falciparum in Three Districts of Northern Tanzania. Antimicrob Agents Chemother 2003, 47:1347-1354.
65. Wilson PE, Alker AP, Meshnick SR: Real-time PCR methods for monitoring antimalarial drug resistance. Trends Parasitol 2005, 21:278-283.
66. Purfield A, Nelson A, Laoboonchai A, Congpuong K, McDaniel P, Miller RS, Welch K, Wongsrichanalai C, Meshnick SR: A new method for detection of pfmdr1 mutations in Plasmodium falciparum DNA using real-time PCR. Malar J 2004, 3:9.
67. Nair S, Brockman A, Paiphun L, Nosten F, Anderson TJ: Rapid genotyping of loci involved in antifolate drug resistance in Plasmodium falciparum by primer extension. Int J Parasitol 2002, 32:852-858.
68. Kamau EM: Field-derived research materials in the African region: challenges and opportunities for the malaria researcher. Acta Trop 2005, 95:167-171.
69. Mberu EK, Mosobo MK, Nzila AM, Kokwaro GO, Sibley CH, Watkins WM: The changing in vitro susceptibility pattern to pyrimethamine/sulfadoxine in Plasmodium falciparum field isolates from Kilifi, Kenya. Am J Trop Med Hyg 2000, 62:396-401.
70. Duraisingh MT, Curtis J, Warhurst DC: Plasmodium falciparum: detection of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Exp Parasitol 1998, 89:1-8.